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Abstract
A 61-year-old man with locally advanced prostate cancer was found to have multiple solid intra-abdominal solid lesions during staging investigations. While some were in the pelvis, they were not located in the common landing sites for prostate cancer metastases, and his prostate specific antigen was not significantly elevated to suggest a high burden of metastatic disease. He reported a history of a blunt abdominal trauma due to a motor vehicle accident more than forty years ago which had been conservatively managed. His staging imaging revealed a lack of a discrete spleen in his left upper abdomen and this raised the suspicion that these solid lesions may represent ectopic splenic tissue. Imaging with nuclear medicine scintigraphy confirmed the lesions in his upper abdomen and pelvis to be splenunculi. He proceeded with a combination of androgen deprivation therapy and external beam radiotherapy for locally advanced, non-metastatic prostate cancer. Although it has been described in patients with low risk prostate cancer, this is the first case report of splenunculi mimicking metastases in a patient with locally advanced prostate cancer. 
INTRODUCTION
Splenosis is the autotransplantation of splenic tissue and formation of scattered tissue deposits secondary to abdominal trauma or splenectomy. It is a benign condition that is generally asymptomatic with a reported incidence of up to 67% of people who have sustained an abdominal injury [1, 2] . Due to increasing rates of abdominal imaging, these cases are now seen more often and the unexpected findings have been mistaken for metastatic disease and hepatoma, as reported in the literature.
CASE REPORT
We present a case of a 61-year-old man with newly diagnosed locally advanced, high risk prostate cancer, with multiple intra-abdominal masses initially mistaken for metastatic disease. This patient was referred to a Urologist with a prostate specific antigen (PSA) of 6.6 ng/mL. He had no significant medical or family history, apart from being involved in a motor vehicle accident at 18 years of age. The accident involved side impact, and he spent three days in hospital for observation but did not undergo surgery. There was no imaging available from that previous admission.
Digital rectal examination found a generally firm and suspicious feeling prostate gland, and trans-rectal ultrasound (TRUS) showed no hypoechoic lesions. TRUS guided prostate biopsy was performed and revealed a large volume of Gleason 4 + 3 = 7 disease occupying 80%-90% of all cores. The specimen from the right base showed extra-prostatic extension of disease, confirming pathological staging as T3.
Staging investigations included a computed tomography (CT) scan of the abdomen and pelvis, whole body bone scan (WBBS) and magnetic resonance imaging (MRI) of the pelvis. WBBS did not reveal any bony abnormalities or metastases. CT showed a 2.4 cm lesion between the liver and right kidney and a 3.4 cm lesion between the bladder and rectum, just superior to the seminal vesicles ( Figure 1 ). The lesions were solid and enhanced with intravenous contrast. There was no discrete spleen in the left upper quadrant, however multiple small lesions lay in this region measuring up to 2 cm in diameter each ( Figure  2 ). There was no pelvic or para-aortic lymphadenopathy present. MRI demonstrated disease within the prostate and no gross extraprostatic extension was present. The MRI clearly displayed the pelvic lesion superior to the seminal vesicles, which was not attached to surrounding structures.
Due to suspicion of ectopic splenic tissue, a heatdamaged radioisotope-labelled red cell scan (99mTc) was performed. All of the lesions seen on CT demonstrated intense tracer uptake and confirmed the presence of multiple intra-abdominal splenunculi (Figure 3) , and excluded abdominal metastatic disease.
Following discussion of treatment options for locally advanced, high risk, non metastatic prostate, the patient elected to undergo external beam radiotherapy in combination with 24 mo of androgen deprivation therapy (ADT).
A PSA rise occurred 21 mo after ADT finished, and the patient required intermittent ADT since then. It has been 8 years since diagnosis and the patient is currently off ADT with no metastatic disease on cross sectional imaging and has a PSA of 0.8 ng/mL.
DISCUSSION
Splenosis is believed to result from the spillage of cells from the splenic pulp during surgical manipulation or following splenic injury. It is reported to develop over an average of 10 years following the insult, and is more common following trauma than iatrogenic causes [3] . The cells can implant in any other location and take their blood supply from surrounding structures; splenosis has been reported as intrathoracic where there is a concomitant diaphragmatic injury or intrahepatic following an emergency splenectomy for trauma [4, 5] . The pathogenesis is generally accepted to be mechanical implantation of cells, however there are case reports of intracranial splenic deposits from purported haematological spread [6] . Whilst it is assumed to be functional splenic tissue, splenosis usually does not have the histological appearance of normal spleen, nor does it form a hilum or a mature capsule. Patients are rarely symptomatic and the condition is most often discovered incidentally on abdominal imaging. This is distinct from an accessory spleen which is congenital and arises from the left side of the dorsal mesogastrium. These deposits are usually found in the region of the gastosplenic ligament or splenopancreatic ligaments, commonly solitary, and if multiple hardly ever exceed six. They are histologically and functionally normal splenic tissue and usually have their own blood supply derived from the splenic artery. They are also usually asymptomatic, but there have been reports of torted accessory spleens and migratory deposits on long vascular pedicles.
The most useful imaging modality by far for investigation of splenosis is nuclear medicine scintigraphy. This can be performed using the agents Technichium-99 sulphur colloid, Technichium-99 heat-damaged erythrocytes or Indium-111 labelled platelets. These agents are widely distributed in the reticuloendothelial system including the liver, bone marrow and spleen. Tc-99m and In-111 labelled platelets are the most sensitive and specific agents for the detection of ectopic splenic tissue [7, 8] . If nuclear scintigraphy is not available or conclusive, the option of percutaneous biopsy of the masses can be pursued but this is often challenging given the varying size and location of the masses.
Multiple published case reports describe the initial misdiagnosis of splenosis as solid tumours, metastases or recurrences for breast, renal, colorectal and hepatocellular cancers, to name a few [9] [10] [11] [12] . Prostate cancer has been reported once in the literature in this context, in a patient with low grade disease that should not have undergone further imaging according to staging guidelines [13] . This is the first report of splenosis in a patient with high risk prostate cancer.
The presence of splenosis following blunt abdominal trauma is under-recognised and, due to its indolent clinical nature, is usually discovered incidentally years later when it is mistaken for malignant disease. This is the first case report of it appearing in the context of high risk, locally advanced prostate cancer. A heat labelled red cell scan is a sensitive and definitive imaging modality for diagnosis. Early consideration of splenosis and diagnostic confirmation is essential to ensuring appropriate care is instituted in each clinical scenario.
COMMENTS

Case characteristics
Soft tissue masses in the context of newly diagnosed prostate cancer.
Clinical diagnosis
Splenunculi.
Differential diagnosis
Metastatic prostate cancer.
Laboratory diagnosis
Routine bloods only, no biopsy was required.
Imaging diagnosis
Technetium-99 scan confirmed splenunculi.
Pathological diagnosis
Ectopic splenic tissue.
Related reports
Multiple other case reports have indicated this differential diagnosis in the staging of many other cancers, but not locally advanced prostate cancer. 
